I

InMed Pharmaceuticals
D

INM

1.69000
USD
0.16
(10.46%)
قبل الجلسة·1.54000USD-0.15000(-8.88%)
حجم التداول
21
الربح لكل سهم
-21
العائد الربحي
-
P/E
-1
حجم السوق
9,023,647
المقالات
المزيد

العنوان: InMed Pharmaceuticals Inc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
InMed Pharmaceuticals Inc is a pharmaceutical company developing a pipeline of disease-modifying small molecule drug candidates targeting CB1 and CB2 receptors. The company's pipeline consists of three separate programs in the treatment ofAlzheimer's, ocular and dermatological indications.